Vaccine is Based on Second Wave, Phase 3 Trials Going On. We Got Good Safety &efficacy ... - Latest Tweet by ANI
The latest Tweet by ANI states, 'Vaccine is based on second wave, phase 3 trials going on. We got good safety &efficacy results.We'll roll out vaccine, as NTAGI gives permission within 72 hours. We can produce 200-300 million doses:Sanjay Singh, CEO, Gennova Biopharmaceuticals Ltd, on India’s 1st mRNA vaccine'
(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)